# Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device

Study · id `cardio:ct-nct01169272` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01169272](<https://clinicaltrials.gov/study/NCT01169272>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01169272

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01169272. Non-randomized; no masking; primary purpose diagnostic. Start 2010-10 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01169272, source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01169272, source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)
- Primary completion: 2011-06 (actual) (ClinicalTrials.gov record NCT01169272, source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01169272, source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT01169272, source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01169272-2014-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device
- Condition: Heart Failure
- Intervention (Device): CRT-SonR 9770
- Lead sponsor: LivaNova
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: LivaNova (`cardio:org-livanova`)

## Provenance

Content hash: 60809376a64cdab4d9e74e1cc872b12cd28ccf847e02d750358e5247e325f0ce
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
